Cargando…
Clinical significance of plasma free DNA in patients with non-small cell lung cancer
OBJECTIVES: Plasma free DNA is a promising new tumor biomarker, which may have applications in clinical diagnosis and treatment of non-small cell lung cancer (NSCLC). METHODS: Plasma free DNA was collected from 120 healthy controls and 116 patients with NSCLC before and after treatment. RESULTS: The...
Autores principales: | Ma, Lanxiang, Du, Jie, Sui, Yongjie, Wang, Shuili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862902/ https://www.ncbi.nlm.nih.gov/pubmed/31547735 http://dx.doi.org/10.1177/0300060519872046 |
Ejemplares similares
-
Association Between Blood Urea Nitrogen Levels and Length of Stay in Patients with Pneumonic Chronic Obstructive Pulmonary Disease Exacerbation: A Secondary Analysis Based on a Multicentre, Retrospective Cohort Study
por: Du, Jie, et al.
Publicado: (2022) -
Expression and clinical significance of miR-139-5p in non-small cell lung cancer
por: Yong-hao, You, et al.
Publicado: (2019) -
Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non‐small cell lung cancer
por: Wakabayashi, Yu, et al.
Publicado: (2020) -
Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysis
por: Yi, Zongbi, et al.
Publicado: (2017) -
Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients
por: Ogawa, E, et al.
Publicado: (2004)